Sustained Release from Ionic-Gradient Liposomes Significantly Decreases ETIDOCAINE Cytotoxicity.
Juliana Damasceno OliveiraLígia Nunes de Morais RibeiroGustavo Henrique Rodrigues da SilvaBruna Renata CasadeiVerônica Muniz CoutoElizabeth Ferreira MartinezEneida de PaulaPublished in: Pharmaceutical research (2018)
A novel formulation is proposed for etidocaine that promotes sustained release and reduces its cytotoxicity. IGLEDC can come to be a tool to reintroduce etidocaine in clinical use.
Keyphrases